Abbott's FreeStyle glucose monitor:
This article was originally published in Clinica
Executive Summary
Abbott Diabetes Care has received US FDA 510(k) clearance to market its FreeStyle Connect blood glucose monitor in point-of-care (POC) settings in hospitals and medical clinics. The device, claims the Alameda, California-based division of Abbott, measures glucose levels using the smallest sample size (0.3 microlitres) required of any POC blood glucose monitoring product on the market. It is also the fastest POC glucose monitoring system available, providing results within an average of 15 seconds, the company added. Abbott added the FreeStyle product to its diabetes portfolio through its 2004 acquisition of Alameda, California-based TheraSense.